To avoid intramuscular injections for other indications, only those injections performed by family physicians and internists (identified through the Registered Physicians Database) were included in the analysis
DAscanio AM, Mullally JA, Frishman WH
However, it's crucial to understand the current state of research and clinical evidence
Early discontinuation may be overestimated if treatment occurred outside the purview of the claims data source 13 KESIMPTA received approval in August 2020, resulting in a relatively limited number of patients with sufficient real-world follow-up data to assess persistence and adherence
Providers who see a patient once and refer them to another provider would be unlikely to meet the criteria for an EBCM episode for that patient, as an EBCM episode is only attributed to a clinician when they bill at least 30 percent of the Part B codes for the episode
Constant sales. Big promises